đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
The purpose of this study is to compare the immune response, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00290303
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of this study is to compare the reactogenicity \& safety of Tri...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-12-11
Trial ID
NCT00317135
Treatments Being Tested
To compare the two formulations of GSK Biologicals' DTPw-HBV vaccine to con...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09-12
Trial ID
NCT00158756
Treatments Being Tested
To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00313911
Treatments Being Tested
This study will evaluate the immunogenicity and safety of the pertussis com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01003431
This study will only include infants born to mothers who are tested as sero...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-10
Trial ID
NCT00317122
Treatments Being Tested
DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00514709
Treatments Being Tested